111 related articles for article (PubMed ID: 8295830)
41. [Results of 131iodine therapy of benign thyroid diseases (author's transl)].
Pronath A; Buttermann G; Dirr W; Pabst HW
MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1970-4. PubMed ID: 6798434
[No Abstract] [Full Text] [Related]
42. [Commentary on the latest DGN procedure guidelines for radioiodine therapy for benign thyroid diseases].
Dietlein M; Drzezga A; Schmidt M
Nuklearmedizin; 2024 Feb; 63(1):4-7. PubMed ID: 37871627
[TBL] [Abstract][Full Text] [Related]
43. Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis.
Hieu TT; Russell AW; Cuneo R; Clark J; Kron T; Hall P; Doi SA
Endocr Relat Cancer; 2012 Oct; 19(5):645-55. PubMed ID: 22851687
[TBL] [Abstract][Full Text] [Related]
44. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient
Gomes-Lima CJ; Wu D; Kharazi PH; Khojekar GJ; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2017 Dec; 27(12):1558-1565. PubMed ID: 29132255
[TBL] [Abstract][Full Text] [Related]
45. Radioactive iodine therapy for malignant and benign thyroid disease: a Canadian national survey of physician practice.
Demeter S; Leslie WD; Levin DP
Nucl Med Commun; 2005 Jul; 26(7):613-21. PubMed ID: 15942482
[TBL] [Abstract][Full Text] [Related]
46. Reflections on cancer treatment and the federal agency regulations.
Saenger EL; Kereiakes JG
Radiology; 1980 Dec; 137(3):865-6. PubMed ID: 7444073
[TBL] [Abstract][Full Text] [Related]
47. Regulations for radioiodine therapy in the United States: current status and the process of change.
Vetter RJ
Thyroid; 1997 Apr; 7(2):209-11. PubMed ID: 9133686
[TBL] [Abstract][Full Text] [Related]
48. [Radioiodine--today's trends in treatment of benign thyroid diseases].
Łabuzek K; Kukla U; Chronowska J; Madej P; Okopień Bogusław
Wiad Lek; 2014; 67(2 Pt 1):80-4. PubMed ID: 25764781
[TBL] [Abstract][Full Text] [Related]
49. [Dose calculations in radioiodine therapy of benign thyroid diseases].
Nielsen JT; Henriksen JH
Ugeskr Laeger; 1995 Nov; 157(47):6591-2. PubMed ID: 7483119
[No Abstract] [Full Text] [Related]
50. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases.
Hänscheid H; Canzi C; Eschner W; Flux G; Luster M; Strigari L; Lassmann M
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1126-34. PubMed ID: 23576099
[TBL] [Abstract][Full Text] [Related]
51. EANM procedure guidelines for therapy of benign thyroid disease.
Stokkel MP; Handkiewicz Junak D; Lassmann M; Dietlein M; Luster M
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2218-28. PubMed ID: 20625722
[TBL] [Abstract][Full Text] [Related]
52. Radioiodine and thyroid disease: the beginning.
Becker DV; Sawin CT
Semin Nucl Med; 1996 Jul; 26(3):155-64. PubMed ID: 8829276
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of fear of radiation and isolation before and after radioiodine therapy.
von Müller F; Happel C; Reinhardt J; Kranert WT; Bockisch B; Gröner D; Ackermann H; Grünwald F
Thyroid; 2014 Jul; 24(7):1151-5. PubMed ID: 24773146
[TBL] [Abstract][Full Text] [Related]
54. [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
Dietlein M; Grünwald F; Schmidt M; Kreissl MC; Luster M; ; ; ;
Nuklearmedizin; 2024 Feb; 63(1):8-20. PubMed ID: 37871629
[TBL] [Abstract][Full Text] [Related]
55. Applying Nuclear Regulatory Commission guidelines to the release of patients treated with sodium iodine-131.
Tuttle WK; Brown PH
J Nucl Med Technol; 2000 Dec; 28(4):275-9. PubMed ID: 11142331
[TBL] [Abstract][Full Text] [Related]
56. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.
Silberstein EB; Alavi A; Balon HR; Clarke SE; Divgi C; Gelfand MJ; Goldsmith SJ; Jadvar H; Marcus CS; Martin WH; Parker JA; Royal HD; Sarkar SD; Stabin M; Waxman AD
J Nucl Med; 2012 Oct; 53(10):1633-51. PubMed ID: 22787108
[No Abstract] [Full Text] [Related]
57. [Dose calculation for thyroid radiation therapy according to MIRD recommendations (author's transl)].
Tautz M
Radiobiol Radiother (Berl); 1976; 17(1):71-5. PubMed ID: 935371
[No Abstract] [Full Text] [Related]
58. Iodine-131 for therapy of thyroid diseases. Physical and biological basis.
Wyszomirska A
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):120-3. PubMed ID: 22936505
[TBL] [Abstract][Full Text] [Related]
59. [Agreements and discrepancies in radioiodine therapy of differentiated thyroid cancer. 2d Heidelberg Meeting of Nuclear Medicine Practitioners on 1.2.91].
Nuklearmedizin; 1992 Aug; 31(4):145-50. PubMed ID: 1355598
[No Abstract] [Full Text] [Related]
60. Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations.
Kloos RT
Thyroid; 2011 Feb; 21(2):97-9. PubMed ID: 21275762
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
